Curis Inc CRIS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:45 PM EDT
0.89quote price arrow up+0.02 (+2.68%)
Volume
5,416
Close
0.8635quote price arrow up+0.0033 (+0.38%)
Volume
980,124
52 week range
0.83 - 15.60
Loading...
  • Open0.873
  • Day High0.8885
  • Day Low0.8351
  • Prev Close0.8602
  • 52 Week High15.60
  • 52 Week High Date06/08/21
  • 52 Week Low0.83
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap79.14M
  • Shares Out91.65M
  • 10 Day Average Volume1.40M
  • Dividend-
  • Dividend Yield-
  • Beta3.17
  • YTD % Change-81.86

KEY STATS

  • Open0.873
  • Day High0.8885
  • Day Low0.8351
  • Prev Close0.8602
  • 52 Week High15.60
  • 52 Week High Date06/08/21
  • 52 Week Low0.83
  • 52 Week Low Date05/12/22
  • Market Cap79.14M
  • Shares Out91.65M
  • 10 Day Average Volume1.40M
  • Dividend-
  • Dividend Yield-
  • Beta3.17
  • YTD % Change-81.86

RATIOS/PROFITABILITY

  • EPS (TTM)-0.56
  • P/E (TTM)-1.53
  • Fwd P/E (NTM)-1.31
  • EBITDA (TTM)-48.247M
  • ROE (TTM)-52.17%
  • Revenue (TTM)10.52M
  • Gross Margin (TTM)95.19%
  • Net Margin (TTM)-490.81%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Curis Inc

There is no recent news for this security.

Profile

MORE
Curis, Inc. is a biotechnology company. The Company is focused on the development of therapeutics for the treatment of cancer. Its clinical stage drug candidates are Emavusertib and CI-8993. Emavusertib is an orally available small molecule inhibitor of Interleukin-1 receptor-associated kinase 4 (IRAK4) which is undergoing testing in a Phase I open-label dose escalating clinical trial in patients with non-Hodgkin lymphomas. CI-8993 is a monoclonal antibody designed to...
Martyn Greenacre
Independent Chairman of the Board
James Dentzer
President, Chief Executive Officer, Director
William Steinkrauss CPA
Chief Financial Officer, Chief Administrative Officer
Address
128 SPRING STREET, BUILDING C, SUITE 500
Lexington, MA
02421
United States

Top Peers

SYMBOLLASTCHG%CHG
TCRX
TScan Therapeutics Inc
3.20+0.44+15.94%
EYEN
Eyenovia Inc
2.12-0.10-4.50%
FIXX
Homology Medicines Inc
1.51+0.07+4.86%
SYBX
Synlogic Inc
1.16+0.07+6.42%
ARDX
Ardelyx Inc
0.694+0.0479+7.41%